Full immunologic reconstitution following nonconditioned bone marrow transplantation for canine X-linked severe combined immunodeficiency

Blood

Volumn 90, Issue 8, 1997, Pages 3214-3221

  Felsburg, Peter J ^a   Somberg, Richard L ^b   Hartnett, Brian J ^b   Suter, Steven F ^b   Henthorn, Paula S ^b   Moore, Peter F ^b   Weinberg, Kenneth I ^b   Ochs, Hans D ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DOG; GENE MUTATION; GENE THERAPY; NONHUMAN; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; X CHROMOSOME LINKED DISORDER;

EID: 0030796576     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.8.3214     Document Type: Article

References (65)

1. Rosen FS, Wedgewood RJP, Eibel M, Griscelli C, Seligmann M, Aiuti F, Kishimoto T, Matsumoto S, Reznik IB, Hanson LA, Thompson RA, Cooper MD, Geha RS, Good RA, Waldmann TA: Primary immunodeficiency diseases. Clin Exp Immunol 99:2, 1995 (suppl 1)
2. Rosen FS, Cooper MD, Wedgewood RJP: The primary immunodeficiencies. N Engl J Med 333:431, 1995
3. Conley M: X-linked severe combined immunodeficiency. Clin Immunol Immunopathol 61:S94, 1991 (suppl)
4. Buckley RH: Breakthroughs in the understanding and therapy of primary immunodeficiency. Pediatr Clin North Am 41:665, 1994
5. Noguchi M, Yi H, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147, 1993
6. Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, Henthorn PS: The interleukin-2 receptor gamma chain maps to Xq 13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 2:1099, 1993
7. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura M, Sugamura K: Cloning of the γ chain of the human IL-2 receptor. Science 257:379, 1992
8. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M. Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE, Leonard WJ: Interleukin-2 receptor γ chain: A functional component of the interleukin-4 receptor. Science 262:1880, 1993
9. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai KI, Sugamura K: Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874, 1993
10. Noguchi M, Nakamura Y, Russell SM, Ziegler SF, Tsang M, Cao X, Leonard WJ: Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor. Science 262:1877, 1993
11. Kondo M, Takeshita T, Higuchi M, Nakamura M, Sudo T, Nishikawa SI, Sugamura K: Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science 263:1453, 1993
12. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Freidmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O, Goldman AS, Schmalstieg FC, IhIe JN, O'Shea JJ, Leonard WJ: Interaction of the IL-2Rβ and γc chains with Jak1 and Jak3: Implications for XSCID and XCID. Science 266:1042, 1995
13. Giri JG, Adhieh M, Eisenman J, Shanebeck S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822, 1994
14. Parkman R: The biology of bone marrow transplantation for severe combined immune deficiency. Adv Immunol 49:381, 1991
15. Fischer A, Landais P, Friedrich W, Morgan G, Gerristen B, Fasth A, Porta F, Griscelli C, Goldman SF, Levinsky R, Vossen J: European experience of bone marrow transplantation for severe combined immunodeficiency. Lancet 2:850, 1990
16. Wijnaendts L, LeDeist F, Grisceli C, Fischer A: Development of immunologic function after bone marrow transplantation in 33 patients with severe combined immunodeficiency. Blood 74:2212, 1989
17. O'Reilly RJ, Keever C, Kernan N, Flomenberg N, Dupont B, Collins N, Brochstein J, Kirkpatrik D, Kapoor N, Burns J, Reisner Y: Investigation of humoral immune deficiencies following T cell-depleted, HLA-haplotype mismatched parental marrow transplants for the treatment of severe combined immunodeficiency disease, in Eibl MM, Rosen FS (eds): Primary Immunodeficiency Diseases. Amsterdam, The Netherlands, Elsevier, 1986, p 301
18. Vossen JM: Bone marrow transplantation in the treatment of primary immunodeficiencies. Ann Clin Res 19:285-292, 1987
19. van Leeuwen JEM, van Tol MJD, Joosten AM, Schellenhens PTA, van den Bergh RL, Waaijen JLM, Oudenman-Gruber NJ, van der Weijden-Fajas CPM, Roos MTL, Gerristen EJA, van den Berg H, Haraldsson A, Khan PM, Voosen JM: Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation of severe combined immunodeficiency. Blood 84:3936, 1994
20. Dror Y, Gallagher R, Wara DW, Colombe BW, Merino A, Benkerron M, Cowan MJ: Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 81:2021, 1993
21. Buckley R, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward F: Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 136:2398, 1986
22. Reinherz EL, Geha R, Rappeport JM, Wilson M, Penta AC, Hussey RE, Fitzgerald KS, Daley JF, Levine H, Rosen FS, Schlossman SF: Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency. Proc Natl Acad Sci USA 79:6047, 1982
23. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS. Cunningham-Rundles S, Dupont B, Hodes MS, Good RA, O'Reilly RJ: Transplantation for severe combined immunodeficiency with HLA, B, C, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61:341, 1983
24. Friedrich W, Goldmann SF, Vette U, Fliedner TM, Heymen B, Peter HH, Reisner Y, Kleihauer E: Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA haploidentical, T-cell-depleted bone marrow. Lancet 1:761, 1984
25. Cowan MJ, Wara DW, Weintrub PS, Pabst H, Ammann AJ: Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells. J Clin Immunol 5:370, 1985
26. Fischer A, Durandy A, deVillartay JP, Vilmer E, Le Deist F, Gerota I, Griscelli C: HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine. Blood 37:444, 1986
27. Buckley R, Schiff SE, Schiff RI, Roberts JL, Markert ML, Peters W, Williams LW, Ward FE: Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 30:92, 1993
28. Moen RC, Horwitz S, Sondel PM, Borcherding WR, Trigg ME, Billing R, Hong R: Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders: Treatment of bone marrow cells with monoclonal antibody CT-2 and complement. Blood 70:664, 1987
29. Himelstein BP, Puck JM, August C, Pierson G, Bunin N: Earlier bone marrow transplantation is better: Two siblings with X-linked severe combined immunodeficiency treated with the same T-cell depleted maternal marrow. J Pediatr 122:289, 1993
30. Barrett MJ, Buckley RH, Schiff SE, Kidd PC, Ward FE: Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism. Clin Exp Immunol 72:118, 1988
31. Minegishi Y, Ishii N, Tsuchida M, Okawa H, Sugamura K, Yata J: T cell reconstitution by haploidentical BMT does not restore the diversification of the Ig heavy chain gene in patients with X-linked SCID. Bone Marrow Transplant 16:801, 1995
32. Puck JM, Nussbaum RL, Conley ME: Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest 79:1395, 1987
33. Jezyk PF, Felsburg PJ, Haskins ME, Patterson DF: X-linked severe combined immunodeficiency in the dog. Clin Immunol Immunopathol 52:173, 1989
34. Felsburg PJ, Somberg RL, Perryman LE: Domestic animal models of severe combined immunodeficiency: Canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses, Immunodefic Rev 3:277, 1992
35. Somberg RL, Robinson JP, Felsburg PJ: T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency. J Immunol 153:4006, 1994
36. Henthorn PS, Somberg RL, Fimian V, Puck JM, Patterson DF, Felsburg PJ: IL-2R γ gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. Genomics 23:69, 1994
37. Ladiges WC, Storb R, Thomas ED: Canine models of bone marrow transplantation. Lab Anim Sci 40:11, 1990
38. Lu P, Zucker E, Esquenazi V, Miller J: Correlation of RFLP typing and MLC reactivity in dogs. Tissue Antigens 37:224, 1991
39. Gebhard DH, Carter PB: Identification of canine T lymphocyte subsets with monoclonal antibodies. Vet Immunol Immunopathol 33:187, 1992
40. Cobbold S, Metcalfe S: Monoclonal antibodies that define canine homologues of human CD antigens: Summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 43:137, 1994
41. Moore PF, Rossitto PV, Olivry T: Development of monoclonal antibodies to canine T cell receptor-γδ (TCR-γδ) and their utilization in the diagnosis of epidermotropic cutaneous T cell lymphoma. Vet Pathol 31:597, 1994
42. Ochs HD, Davis SD, Wedgewood RJ: Immunologic response to bacteriophage φX174 in immunodeficiency disease. J Clin Invest 50:2559, 1971
43. Ochs HD, Storb R, Thomas ED, Kolb HJ, Graham TC, Mickelson E, Parr M, Rudolph RH: Immunologic reactivity in canine marrow graft recipients. J Immunol 113:1039, 1974
44. Storek J, Witherspoon RP, Storb R: T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 16:413, 1995
45. Weinberg K, Annett G, Kashyap A, Lenarsky C, Forman SJ, Parkman R: The effect of thymic function on immunocompetence following bone marrow transplantation. Biol Blood Bone Marrow Transplant 1:18, 1995
46. Kelly WD: The thymus and lymphoid morphogenesis in the dog. Fed Proc 20:600, 1963
47. Snyder PW, Kazacos EA, Felsburg PJ: Histologic characterization of the thymus in canine X-linked severe combined immunodeficiency. Clin Immunol Immunopathol 67:55, 1993
48. Akbar AN, Terry L, Timms A, Beverley PCL, Janossy G: Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 140:2171, 1988
49. + T cells. Immunology 69:460, 1990
50. + peripheral blood lymphocytes. J Exp Med 179:857, 1994
51. + T cells from CD45RA to CD45RO is accompanied by cell activation and proliferation. Cytometry 19:343, 1995
52. Parker CM, Groh V, Band H, Porcelli SA, Morita C, Fabbi M, Glass D, Strominger JL, Brenner MB: Evidence for extrathymic changes in the T cell receptor γδ repertoire. J Exp Med 171:1597, 1990
53. Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE: T cell regeneration after bone marrow transplantation: Differential CD45 isofonn expression on thymic-derived versus thymic-independent progeny. Blood 82:2585, 1993
54. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 332:143, 1995
55. Gougeon ML, Drean G, LeDeist F, Dousseau M, Fevrier M, Diu A, Theze J, Griscelli C, Fischer A: Human severe combined immunodeficiency disease. Phenotypic and functional characteristics of peripheral blood B lymphocytes. J Immunol 145:2873, 1990
56. Conley M, Lavoie A. Briggs C, Brown P, Guerra C, Puck JM: Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci USA 85:3090, 1988
57. Puck JM, Steward CC, Nussbaum RL: Maximum-likelihood analysis of human T cell X chromosome inactivation patterns: Normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet 50:742, 1992
58. Ikuta K, Kina T, MacNeil I, Uchida N, Peault B, Chien YH, Weissman IL: A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 62:863, 1990
59. Weissman IL: Developmental switches in the immune system. Cell 76:207, 1994
60. Lansdorp PM, Dragowska W, Mayani H: Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178:787, 1993
61. - cells in cord blood and bone marrow. Blood 86:3745, 1995
62. Deeg HJ, Storb R: Canine bone marrow transplantation models. Curr Top Vet Res 1:103, 1994
63. DiSanto JP, Muller W, Guy-Grand D, Fischer A, Rajewsky R: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 92:377, 1995
64. Cao A, Shores EW, Hu-Li J, Anver MR, Keisall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, Paul WE, Katz SI, Love PE, Leonard WJ: Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2:223, 1995
65. Ohbo K, Suda T, Hashiyama M, Mantani A, Ikebe M, Miyakawa K, Moriyama M, Nakamura M, Katsuki M, Takahashi K, Yamaura KI, Sugamura K: Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain. Blood 87:956, 1996